Executive Committee:
- Paul Petrelli, President & General Manager, Jazz Pharmaceuticals (Chair)
- Gordon McCauley, President and CEO, adMare Innovations (Vice Chair)
- Chris Aiello, Franchise Head, Sanofi-Genzyme (Treasurer)
- Roberto Bellini, President & CEO, Bellus Health (Member at Large)
- Andrew Casey, President & CEO, BIOTECanada (Secretary)
Directors:
- Norma Biln, CEO, Augurex
- Neal Carter, President & Founder, Okanagan Specialty Fruits
- Alok Kanti, General Manager, Bayer Canada
- Melissa Koomey, Vice President & General Manager, Gilead Sciences Canada
- A.J. (Sandy) Marshall, Chairman, Bioindustrial Innovation Canada
- Jeffrey Miller, General Manager, Alnylam Pharmaceuticals Canada
- John Norman, Partner, Gowling WLG (Canada) LLP
- Alan Reba, General Manager, Bristol-Meyers Squibb
- Sanj Singh, President & CEO, Temple Therapeutics B.V.
- Jamie Stiff, Managing Director, Genesys Capital
- Oliver Technow, CEO, BioVectra Inc.
- Shermaine Tilley, Managing Partner, CTI Life Sciences Fund
- Dan Wattier, CEO, ImStar Therapeutics